Inhaled aztreonam lysine for the treatment of deficits in...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/427 (2006.01) A61P 11/00 (2006.01) A61P 31/04 (2006.01)

Patent

CA 2701118

Provided is the use of an inhalable aerosol of azlreonam lysine in the manufacture of a medicament for treating the health-related quality-of-life (HRQOL) symptoms of lung disease. The use is suitable for the sustainable long term treatment of HRQOL symptoms.

L'invention porte sur l'utilisation d'un aérosol inhalable d'aztréonam lysine dans la fabrication d'un médicament pour traiter les symptômes de qualité de vie liée à la santé (HRQOL) d'une maladie pulmonaire. L'utilisation est appropriée pour le traitement durable à long terme des symptômes de HRQOL.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Inhaled aztreonam lysine for the treatment of deficits in... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhaled aztreonam lysine for the treatment of deficits in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhaled aztreonam lysine for the treatment of deficits in... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1365048

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.